Skip to main content
Fig. 7 | BMC Biotechnology

Fig. 7

From: Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates

Fig. 7

Reactivity of individual mouse sera (OD405 of a 1:300 serum dilution from Figs. 5 and 6) with homologous group 2 (a) and heterologous group 1 HA antigens (b) after immunization with LAH3-HBc VLPs (N = 16) or after mock (N = 16) immunization. c shows the same aggregated results by reactivity with group 1 or group 2 antigens. The threshold for positivity (dotted line) is defined by comparison to the mock i.e. adjuvant only immunized mice

Back to article page